Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
from Top India News- News18.com https://ift.tt/3eXZuzW
Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19
July 27, 2021
Tags